Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dicloxacillin and Skin Microbiome in Atopic Dermatitis
NCT05578482Phase 4Unknown
- Start
- Oct 2022
- Primary completion
- May 2023
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of dicloxacillin in atopic dermatitis (AD). Status: unknown.
02
Drugs
dicloxacillin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05578482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05578482.